Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15044733rdf:typepubmed:Citationlld:pubmed
pubmed-article:15044733lifeskim:mentionsumls-concept:C0015127lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C0058099lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:15044733lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:15044733pubmed:issue4lld:pubmed
pubmed-article:15044733pubmed:dateCreated2004-3-26lld:pubmed
pubmed-article:15044733pubmed:abstractTextThe flavin enzyme dihydroorotate dehydrogenase (DHOD; EC 1.3.99.11) catalyzes the oxidation of dihydroorotate to orotate, the fourth step in the de novo pyrimidine biosynthesis of UMP. The enzyme is a promising target for drug design in different biological and clinical applications for cancer and arthritis. The first crystal structure of the class 2 dihydroorotate dehydrogenase from rat has been determined in complex with its two inhibitors brequinar and atovaquone. These inhibitors have shown promising results as anti-proliferative, immunosuppressive, and antiparasitic agents. A unique feature of the class 2 DHODs is their N-terminal extension, which folds into a separate domain comprising two alpha-helices. This domain serves as the binding site for the two inhibitors and the respiratory quinones acting as the second substrate for the class 2 DHODs. The orientation of the first N-terminal helix is very different in the two complexes of rat DHOD (DHODR). Binding of atovaquone causes a 12 A movement of the first residue in the first alpha-helix. Based on the information from the two structures of DHODR, a model for binding of the quinone and the residues important for the interactions could be defined. His 56 and Arg 136, which are fully conserved in all class 2 DHODs, seem to play a key role in the interaction with the electron acceptor. The differences between the membrane-bound rat DHOD and membrane-associated class 2 DHODs exemplified by the Escherichia coli DHOD has been investigated by GRID computations of the hydrophobic probes predicted to interact with the membrane.lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:languageenglld:pubmed
pubmed-article:15044733pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:citationSubsetIMlld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15044733pubmed:statusMEDLINElld:pubmed
pubmed-article:15044733pubmed:monthAprlld:pubmed
pubmed-article:15044733pubmed:issn0961-8368lld:pubmed
pubmed-article:15044733pubmed:authorpubmed-author:LarsenSineSlld:pubmed
pubmed-article:15044733pubmed:authorpubmed-author:JohanssonEvaElld:pubmed
pubmed-article:15044733pubmed:authorpubmed-author:HansenMajbrit...lld:pubmed
pubmed-article:15044733pubmed:authorpubmed-author:LöfflerMonika...lld:pubmed
pubmed-article:15044733pubmed:authorpubmed-author:UllrichAlexan...lld:pubmed
pubmed-article:15044733pubmed:authorpubmed-author:Le...lld:pubmed
pubmed-article:15044733pubmed:authorpubmed-author:AntalTorbenTlld:pubmed
pubmed-article:15044733pubmed:issnTypePrintlld:pubmed
pubmed-article:15044733pubmed:volume13lld:pubmed
pubmed-article:15044733pubmed:ownerNLMlld:pubmed
pubmed-article:15044733pubmed:authorsCompleteYlld:pubmed
pubmed-article:15044733pubmed:pagination1031-42lld:pubmed
pubmed-article:15044733pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
pubmed-article:15044733pubmed:meshHeadingpubmed-meshheading:15044733...lld:pubmed
More...